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ABSTRACT. In the present work, the ethyl 2-(1H-benzo[d]imidazol-2-yl)acetate (3) was subjected to a series of  
heterocyclization reactions through its reaction with different chemical reagents. The resulting molecules were 
thiophene, pyrazole, coumarin derivatives incorporated benzo[d]imidazole moiety. All the synthesized compounds 
were determined by elemental analysis, 1H NMR, 13C NMR, and MS. The antitumor evaluations of the newly 
synthesized products toward the three cancer cell lines MCF-7 (breast adenocarcinoma), NCI-H460 (non-small 
cell lung cancer), and SF-268 (CNS cancer) showed that compounds 5a, 9b, 9c, 17, 23b and 38 were of the 
highest potencies among the synthesized compounds. 
  




In recent years, benzimidazole derivatives have provided a large number of biologically active 
compounds that have been intensively used in medicinal chemistry as drugs. They are structural 
isosteres of naturally occurring nucleotides, which allow them to interact easily with the 
biopolymers of the living system and different kinds of biological activity have been obtained. 
Some 2-aminobenzimidazoles displayed an appreciable antimicrobial effect. Their 
corresponding carbamate derivatives have been synthesized for their significant in vivo 
antifilarial activity [1]. Concerning the high affinity that they display towards a variety of 
enzymes and protein receptors, they could be considered as pivotal structures in drug design [2].  
  
 
Figure 1. Examples of topoisomerase inhibitors containing benzimidazole nucleus. 
 
Optimization of benzimidazole-based structures has resulted in marketed drugs, e.g. 
Omeprazole [3] and Pimobendan [4] that are therapeutically useful in the management of peptic 
ulcer and congestive heart failure respectively. Many derivatives of benzimidazoles are well 
known for their antimicrobial [5, 6] anthelmintic [7] antiviral [8, 9] and antifungal [10, 11] 
activities. Since 1985, benzimidazole containing compounds have been reported as well known 
anticancer agents [12, 13].  The role of mammalian DNA topoisomerases as molecular targets 
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for anticancer drugs has been recognized. Some benzimidazoles have been reported as top 
isomerase inhibitors, e.g. Hoechst 33258 and Hoechst 33342 (Figure 1) [14, 15].  On extension 
of this work, head to head bis-benzimidazole compounds approved high efficacy as DNA 
binders [16]. Some widely used anticancer drugs such as RAF265 (CHIR-265; Novartis 
Pharmaceuticals, Basel, Switzerland) and AZD6244 (ARRY-142886;AstraZeneca, London, 
England) are known to contain benzimidazole moiety. RAF265 resulted in a reduction in tumor 
cell growth and in tumor cell apoptosis [17].  
 
RESULTS AND DISCUSSION 
 
In the present work, we synthesized a series of heterocyclic compounds derived from ethyl 2-
(1H-benzo[d]imidazol-2-yl)acetate together with their antitumor evaluations. Thus, the reaction 
of o-phenylenediamine (1) with diethylmalonate (2) in an oil bath at 120 oC gave ethyl 2-(1H-
benzo[d]imidazol-2-yl)acetate (3), its structure was based on analytical and spectral data. 
Compound 3 was used in many acyclic and heterocyclic reactions. Thus, compound 3 reacted 
with either aniline (4a) or 4-methylaniline (4b) to give the anilide derivatives 5a and 5b, 
respectively. The structures of compounds 5a and 5b were based on their respective analytical 
and spectral data. Thus, the 1H NMR spectrum 5a showed the presence of a singlet at  4.93 
ppm corresponding to the CH2 group a multiplet at  7.25-7.41 ppm confirming the presence of 
the two phenyl protons and two signals at  8.26 and 8.32 ppm corresponding to the presence of 
the two NH groups. In addition the 13C NMR data showed beside the expected signals the 
presence of a signal at 54.2 for the CH2 group and two signals at 1.72 and 164.8 indicating the 
C=N and CO groups, respectively.  
Compound 3 reacted with any of benzaldehyde (6a), 4-mathoxybenzaldehyde (6b) or 4-
chlorobenzaldehyde (6c) to give the benzylidene derivatives 7a-c, respectively. Either of 
compound 7a with either hydrazine hydrate (8a) or phenylhydrazine (8b) or compound 7c with 
hydrazine hydrate gave the pyrazole derivatives 9a-c, respectively. Compound 7a reacted with 
malononitrile (10) to give the ethyl 1-amino-2-cyano-3-phenylbenzo[4,5]imidazo[1,2-
a]pyridine-4-carboxylate (11) (Scheme 1). The analytical and spectral data of compound 11 are 
in agreement with their respective analysis. Thus, the 1H NMR spectrum 11 showed (beside the 
expected signals) a triplet and quartet, a singlet (D2O exchangeable) at  4.83 ppm confirming 
the presence of the NH2 group. In addition the 
13C NMR showed the presence of signals at 116.8 
for the CN group, signals at 144.3, 143.2, 140.8, 137.3, 128.8, 126.2, 125.9, 125.4, 124.3, 123.5, 
120.1, 119.3 equivalent to the pyridine C-2, C-3, C-4, C-5 and the C6H5, C6H4 groups. 
The reactivity of compound 3 towards condensation reactions was studied in order to 
produce biologically active products. Thus, compound 3 reacted with acetophenone (12) in an 
oil bath containing ammonium acetate to give the Knoevenagel condensation product 13. On the 
other hand, the reaction of compound 3 with either cyclopentanone (14a) or cyclohexanone 
(14b) gave the products 15a and 15b, respectively.  
The analytical and spectral data of 15a,b were in agreement with their respective structures.  
Thus, the 1H NMR spectrum of 15a showed (beside the expected signals) the presence the two 
multiplets at 1.18-1.24 and 2.9-2.21 ppm indicating the presence of the four cyclohexene CH2 
groups and a singlet at8.32 ppm (D2O exchangeable) indicating the presence of the NH group.  
The reaction of compound 3 with acetylacetone (16) gave the benzo[4,5]imidazo[1,2-
a]pyridine derivative 17. Similarly, the reaction of compound 3 with malononitrile (10) gave the 
benzo[4,5]imidazo[1,2-a]pyridine derivative 18. 
Compound 3 reacted with hydrazinehydrate (8a) to give the hydrazide derivative 19. On the 
other hand the reaction of compound 3 with phenylisothiocyanate (20) gave the 1,2-
dihydrobenzo[4,5]imidazo[1,2-c]pyrimidin-3(4H)-one derivative 21 (Scheme 2). The structure 
of compound 21 was based on its analytical and spectral data. Thus, the 1H NMR spectrum 21 
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showed the presence of a singlet at  5.90 ppm indicating the presence of the pyrimidine CH2 
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The reactivity of compound 3 towards thiophene synthesis using the Gewald's thiophene 
synthesis was studied. Thus, the reaction of compound 3 with elemental sulfur and either of 
malononitrile (10) or ethyl cyanoacetate (22) gave the thiophene derivatives 23a and 23b, 
respectively. Moreover, the reaction of compound 3 with ethylorthoformate (24) gave the 
ethoxymethylyeno derivatives 25. On the other hand, the multi-component reaction of 
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compound 3 with ethyl orthoformate (24) and aniline (4a) gave the phenylaminomethyleno 
derivative 26. The analytical and spectral data of compounds 25 and 26 were consistent with 
their respective structures (see experimental section). The multi-component reaction (MCRs) of 
compound 3 with ethyl orthoformate (24) and malononitrile (10) gave the ethyl 1-amino-2-
cyano-3-ethoxybenzo[4,5]imidazo[1,2-a]pyridine-4-carboxylate 28. Formation of the latter 
product took place through the intermediate formation of 28 followed by the Micheal type 
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The reaction of compound 3 with salicylaldehyde (29) in ethanol containing piperidine gave 
the coumarin derivative 30. The structure of compound 30 (Scheme 3) was based on analytical 
and spectral data. Thus, the 1H NMR spectrum 30 showed a singlet at  6.09 corresponding to 
the coumarin H-4 and a singlet at   8.09 (D2O exchangeable) indicating the presence of the NH 
group. In addition the 13C NMR spectrum showed the presence of signals at 131.5, 130.3, 129.4, 
128.2, 127.3, 126.8, 126.4, 125.3, 124.1, 123.6, 122.4, 121.6 equivalent to the two phenyl 
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groups and two signals at  173.4 and 164.6 indicating the presence of the C=N and C=O groups, 
respectively. 
Further confirmations for the structure of compound 30 were obtained through studying its 
reactivity towards some chemical reagents. Thus, compound 30 reacted with either -
chloroacetone (31a) or ethyl -cholroacetate (31b) to give the 1H-benzo[4,5]imidazo[1,2-
a]chromeno[3,4-c]pyridin-1-one derivatives 32a and 32b, respectively. Formation of the latter 
product was explained in terms of the first reaction of the NH of compound 30 with the -chloro 
group of 32a or 32b followed by either elimination of water or ethanol, respectively. Moreover, 
the reaction of compound 30 with chloroacetylchloride (33) gave the 8-hydroxy-1H-
benzo[4,5]imidazo[1,2-a]chromeno[3,4-c]pyridin-1-one 35 its analytical and spectral data 
confirm the proposed structure. The reaction of compound 30 with acetic anhydride (36) gave 
the N-acetyl derivative 37. Our trials to make cyclization of 37 under different conditions were 
failed. Finally, the reaction of compound 30 with phenylisothiocyanate (20) gave the N-
phenylthiourea derivative 38 (Scheme 4). 
 
Antitumor and normal cell line activity tests 
 
Reagents. Fetal bovine serum (FBS) and L-glutamine, were from Gibco Invitrogen Co. 
(Scotland, UK). RPMI-1640 medium was from Cambrex (New Jersey, USA). Dimethyl 
sulfoxide (DMSO), doxorubicin, penicillin, streptomycin and sulforhodamine B (SRB) were 
from Sigma Chemical Co. (Saint Louis, USA).  
 
Cell cultures. Three human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-
small cell lung cancer), and SF-268 (CNS cancer) were used. MCF-7 was obtained from the 
European Collection of Cell Cultures (ECACC, Salisbury, UK), NCI-H460, SF-268 and normal 
fibroblast cells (WI 38) were kindly provided by the National Cancer Institute (NCI, Cairo, 
Egypt). They grow as monolayer and routinely maintained in RPMI-1640 medium 
supplemented with 5% heat inactivated FBS, 2 M glutamine and antibiotics (penicillin 100 
U/mL, streptomycin 100 µg/mL), at 37 oC in a humidified atmosphere containing 5% CO2. 
Exponentially growing cells were obtained by plating 1.5 x 105 cells/mL for MCF-7 and SF-268 
and 0.75 x 104 cells/mL for NCI-H460, followed by 24 h of incubation. The effect of the 
vehicle solvent (DMSO) on the growth of these cell lines was evaluated in all the experiments 
by exposing untreated control cells to the maximum concentration (0.5%) of DMSO used in 
each assay. 
 
Tumor cell growth assay. The effects of the synthesized compounds on the in vitro growth of 
human tumor cell lines were evaluated according to the procedure adopted by the National 
Cancer Institute (NCI, USA) in the ‘In vitro Anticancer Drug Discovery Screen’ that uses the 
protein-binding dye sulforhodamine B to assess cell growth. Briefly, exponentially, cells 
growing in 96-well plates were then exposed for 48 h to five serial concentrations of each 
compound, starting from a maximum concentration of 150 µM. Following this exposure period 
adherent cells were fixed, washed, and stained. The bound stain was solubilized and the 
absorbance was measured at 492 nm in a plate reader (Bio-Tek Instruments Inc., Power wave 
XS, Wincoski, USA). For each test compound and cell line, a dose–response curve was obtained 
and the growth inhibition of 50% (GI50), corresponding to the concentration of the compounds 
that inhibited 50% of the net cell growth was calculated as described elsewhere. Doxorubicin 
was used as a positive control and tested in the same manner. 
Results are given in cconcentrations that were able to cause 50% of cell growth inhibition 
(GI50) after a continuous exposure of 48 h and show means ± SEM of three-independent 
experiments performed in duplicate.  
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Structure activity relation ship 
 
It is clear from Table 1 that many of the synthesized compounds showed high activity against 
the three cancer cell lines. It is obvious that compound 5a showed higher potency than 
compound 5b as it seemed that the presence of the 4-methylphenyl group responsible for the 
decreasing of compound 5b. On the other hand the compounds 7a-c showed low potencies 
against the three cancer cell lines. Considering the pyrazole derivatives 9a-c, it is obvious that 
compounds 9b (R = H, X = Cl) and compound 9c (R = Ph, X = H) revealed high potencies 
against the three cancer cell lines whereas compound 11 showed low inhibitions. Considering 
compounds 13, 5a,b and 17 it is clear that the ethyl 1,3-dimethylbenzo[4,5]imidazo[1,2-
a]pyridine-4-carboxylate (17) showed the highest inhibitions among the four compounds. The 
same also for compounds 18, 19, 21, 23a and 23b, it is clear that compound 23b showed the 
highest inhibitions and its reactivity was due to the presence the COOEt group  attached to the 
thiophene ring. Considering compounds 25, 26, 28 and 30, it is clear that compound 30 was the 
only one with high potencies. For compounds 32a, 32b, 37 and 38 it is obvious from Table 1 
that the  2-(2-oxo-2H-chromen-3-yl)-N-phenyl-1H-benzo[d]imidazole-1-carbothioamide 38 was 
of the highest potency among these four compounds. Its reactivity is attributed to the presence 
of the coumarin and the N-phenylthiourea moieties. 
 
Table 1. Effect of the newly synthesized compounds on growth of three human tumor cells. 
 
 GI50 (mol L-1)  
Compound MCF-7 NCI-H460 SF-268 WI 38 
3 23.6 ± 4.1 34.6 ± 12.1 45.4 ± 2.2 >100 
5a 0.21 ± 0.04 0.12 ± 0.04 0.08 ± 0.006 40.0  ± 1.3 
5b 36.6 ± 10.2 33.0 ± 8.6 38.6 ±  8.0 8 >100 
7a 23.2 ± 2.4 26.6 ± 2.8 22.8 ± 8.5 38.2 ± 2.6 
7b 22.4 ± 5.8 26.7 ± 8.2 31.4 ± 2.4 18.6 ±4.0 
7c 20.8 ±  8.30 22.8 ± 4.32 22.8 ± 6.23 >100 
9a 38.2 ± 3.6 36.3 ± 12.5 40.6 ± 8.8 >100 
9b 0.01 ± 0.001 0.02 ± 0.006 0.06 ± 0.002 >100 
9c 0.02 ± 0.001 0.03 ± 0.008 0.06 ± 0.008 >100 
11 30.0 ± 1.4 20.8 ± 4.3 20.3 ± 2.8 >100 
13 12.6 ± 2.01 18.6 ± 6.06 30.4 ± 2.36 30.6 ± 10.2 
15a 32.6 ± 1.3 29.7 ± 1.6 20.2 ± 8.9 55.8±8.7 
15b 22.4 ± 2.10 10.4 ± 3.0 8.63 ± 2.8 >100 
17 0.08 ±  0.002 0.08 ± 0.003 0.02 ± 0.002 >100 
18 38.1 ± 1.0 27.8 ± 4.3 12.3 ± 2.4 >100 
19 38.4 ± 8.3 29.3 ± 10 36.40 ± 2.13 60.1 ± 2.3 
21 13.8 ± 2.6 12.1 ± 4.2 29.2 ±  4.1 >100 
23a 2.82 ± 2.8 6.9 ± 2.2 3.0 ± 1.8 77.5 ±5.1 
23b 0.06 ± 0.007 0.06 ± 0.006 0.02 ± 0.008 >100 
25 21.2  ± 4.2 30.0 ± 8.0 20.59 ± 4.01 >100  
26 21.2 ± 6.1 24.0 ±4.7 10.39 ± 6.80 >100 
28 32.0 ± 7.3 26.7 ± 2.8 30.4 ± 2.9 32.6 ± 6.4 
30 1.2 ± 0.4 0.3 ± 0.16 2.8 ± 0.06 22.4 ±1.6 
32a 26.6 ± 8.5 29.3 ± 12.3 18.4 ± 2.8 68.2 ± 2.0 
32b 24.1 ± 10.4 30.8 ± 10.8 26.1 ± 2.8 25.2 ± 0.8 
35 44± 4.31 29.03 ± 8.01 20.6 ± 4.0 28.2 ± 8.2 
37 22.7 ± 6.2 36.5 ± 6.4 31.5 ± 8.0 >100 
38 0.08 ± 0.004 0.05 ± 0.002 0.06 ± 0.001 28.0  ± 4.9 
Doxorubicin 0.04 ±0.008 0.09±0.008 0.09±0.007 > 100 
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From Table 1 it is clear that the cytotoxic effect of the cyclic compounds. Compounds 5a, 
9a, 9b, 17, 23a, 23b, 30, 38 exhibited optimal cytotoxic effect against cancer cell lines, with 
GI50,s in the M range. On the other hand, compounds 11, 13, 15a, 15b, 18, 19, 21, 25, 27, 29, 
32a, 32b, 35 and 37 showed low cytotoxicity effect toward the three cancer lines. It is clear 
from the demostracted “SAR” that the presence of electronegative groups together with the 









All melting points were determined on an electrothermal apparatus (Büchi 535, Switzerland) in 
an open capillary tube and are uncorrected. 13C-NMR and 1H-NMR spectra were recorded on 
Bruker DPX200 instrument in DMSO with TMS as internal standard for protons and solvent 
signals as internal standard for carbon spectra. Chemical shift values are mentioned in δ (ppm). 
Mass spectra were recorded on EIMS (Shimadzu) and ESI-esquire 3000 Bruker Daltonics 
instrument. Elemental analyses were carried out by the Microanalytical Data Unit Ludwig-
Maximilians-Universitat-Munchen, Germany. The progress of all reactions was monitored by 
TLC on 2 x 5 cm pre-coated silica gel 60 F254 plates of thickness of 0.25 mm (Merck). 
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)acetate (3)  
 
To the dry solid of o-phenylene diamine (1.08 g, 0.01 mol) diethylmalonate (1.60 g, 0.01 mol) 
was added. The reaction mixture was heated in an oil bath at 120 oC for 1 h then left to cool. The 
remaining product was triturated with ethanol and the formed solid product was collected by 
filtration. Brown crystals from ethanol; yield: 1.73 g (85%); m.p. 130 oC. IR, : 3465-3328 
(NH), 3058 (CH aromatic), 2973, 2848 (CH3, CH2), 1703 (C=O), 1640 (C=N), 1615 (C=C). 
1H-
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NMR, :1.14 (t, 3H, J = 6.85 Hz, CH3), 4.26 (q, 2H, J = 6.85 Hz), 4.82 (s, 2H, CH2), 7.28-7.39 
(m, 4H, C6H4), 8.30 (s, 1H, NH, D2O exchangeable). 
13C NMR (DMSO): 16.2 (ester CH3), 52.8 
(ester CH2), 54.3 (CH2), 121.4, 122.8, 123.6, 124.3, 126.4, 126.8 (C6H4), 172.8 (C=N); Anal. 
calcd for C11H12N2O2: C, 64.69; H, 5.92; N, 13.72%. Found: C, 64.48; H, 6.20; N, 13.80%. MS: 
m/z: (%) 204 (M+, 33%).   
 
General procedure for the synthesis of the anilide derivatives 5a,b 
 
To a solution of compound 3 (2.04 g, 0.01 mol) in dimethylformamide (30 mL) either aniline 
(0.93 g, 0.01 mol) or 4-methylaniline (1.08 g, 0.01 mol) was added. The reaction mixture, in 
each case, was heated under reflux for 4 h then poured onto ice/water mixture containing few 
drops of hydrochloric acid and the formed solid product was collected by filtration.  
 
2-(1H-Benzo[d]imidazol-2-yl)-N-phenylacetamide (5a). Light brown crystals from ethanol; 
yield: 2.08 g (80%); m.p. 220-222 oC. IR, : 3472-3324 (2NH), 3050 (CH aromatic), 1680 
(C=O), 1648 (C=N), 1629 (C=C). 1H-NMR, : 4.93 (s, 2H, CH2), 7.25-7.41 (m, 9H, C6H5, 
C6H4), 8.26, 8.32 (2s, 2H, 2NH, D2O exchangeable). 
13C NMR (DMSO): 54.8 (CH2), 119.2, 
120.8, 122.8, 123.6, 124.3, 125.2, 126.1, 127.3, 128.3, 129.2, (C6H5, C6H4), 164.8 (CO), 172.4 
(C=N); Anal. calcd for C15H13N3O: C, 71.70; H, 5.21; N, 16.72%. Found: C, 71.83; H, 5.08; N, 
16.82%. MS: m/z: (%) 251 (M+, 24%). 
 
2-(1H-Benzo[d]imidazol-2-yl)-N-(p-tolyl)acetamide (5b). Yellow crystals from ethanol; yield: 
1.93 g (73%); m.p. 92 oC. IR, :  3480-3349 (2NH), 1686 (C=O), 1644 (C=N), 1632 (C=C). 1H-
NMR: : 3.17 (s, 3H, CH3), 4.89 (s, 2H, CH2), 7.27-7.36 (m, 8H, 2C6H4), 8.29, 8.30 (2s, 2H, 
2NH, D2O exchangeable). 
13C NMR (DMSO): 24.8 (CH3), 54.6 (CH2), 120.1, 120.2, 121.8, 
122.7, 123.3, 123.9, 126.6, 127.2, 129.1, 129.5, (C6H5, C6H4), 164.6 (CO), 172.3 (C=N); Anal. 
calcd for C16H15N3O: C, 72.43; H, 5.70; N, 15.84%. Found: C, 72.38; H, 5.66; N, 15.69%. MS: 
m/z: (%) 265 (M+, 24%). 
 
General procedure for the synthesis of the benzylidene derivatives 7a-c 
 
To a solution of compound  3 (2.04 g, 0.01 mol) in ethanol (30 mL) containing piperidine (0.50 
mL) either benzaldehyde (1.06 g, 0.01 mol) or 4-methoxy benzaldehyde (1.31 g, 0.01 mol) or 4-
chlorobenzaldehyde (1.34 g, 0.01 mol) was added. The reaction mixture, in each case, was 
heated under reflux for 3 h then poured onto ice/water mixture containing few drops of 
hydrochloric acid and the formed solid product was collected by filtration.  
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)-3-phenylacrylate (7a). Gray crystals from ethanol; yield: 
2.45 g (77%); m.p. > 300 oC. IR, : 3478-3329 (NH), 3057 (CH aromatic), 2962, 2873 (CH3, 
CH2), 1688 (C=O), 1646 (C=N), 1630 (C=C).
 1H-NMR: : 1.14 (t, 3H, J = 7.66 Hz, CH3), 4.21 
(q, 2H, J = 7.66 Hz, CH2), 6.24 (s, 1H, CH=C), 7.29-7.38 (m, 9H, C6H5, C6H4), 8.26 (s, 1H, NH, 
D2O exchangeable). 
13C NMR (DMSO): 16.3 (ester CH3), 52.5 (ester CH2), 89.3, 90.2 (CH=C),   
120.6, 122.1, 123.2, 123.9, 124.1, 124.6, 125.8, 126.2, 127.8, 128.2, (C6H5, C6H4), 164.8 (CO), 
172.6 (C=N); Anal. calcd for C18H16N2O2: C, 73.95; H, 5.52; N, 9.58%.  Found: C, 72.73; H, 
5.49; N, 9.37%. MS: m/z: (%) 292 (M+, 64%).  
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)-3-(4-methoxyphenyl)acrylate (7b). Light brown crystals 
from ethanol; yield: 2.22 g (69%); m.p. 151 oC. IR, : 3484-3362 (NH), 3055 (CH aromatic), 
2949, 2868 (CH3, CH2), 1686 (C=O), 1640 (C=N), 1626 (C=C). 
1H-NMR: : 1.16 (t, 3H, J = 
7.08 Hz, CH3), 3.14 (s, 3H, CH3), 4.23 (q, 2H, J = 7.08 Hz, CH2), 6.26 (s, 1H, CH=C), 7.27-7.36 
(m, 8H, 2 C6H4), 8.26 (s, 1H, NH, D2O exchangeable). 
13C NMR (DMSO): 16.4 (ester CH3), 
53.8 (OCH3), 52.3 (ester CH2), 89.1, 90.4 (CH=C), 120.3, 122.8, 123.0, 123.7, 124.4, 125.8, 
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126.3, 127.6, 128.2, 129.4 (C6H5, C6H4), 164.6 (CO), 172.6 (C=N);  Anal. calcd for C19H18N2O3: 
C, 70.79; H, 5.63; N, 8.69%. Found: C, 70.82; H, 5.73; N, 8.59%. MS: m/z: (%) 322 (M+, 83%).  
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)-3-(4-chlorophenyl)acrylate (7c). Yellow crystals from 
ethanol; yield: 2.61 g (80%); m.p. 103 oC.  IR, : 3477-3349 (NH), 3054 (CH aromatic), 2933, 
2863 (CH3, CH2), 1689 (C=O), 1644 (C=N), 1631 (C=C). 
1H-NMR: : 1.14 (t, 3H, J = 7.27 Hz, 
CH3), 4.21 (q, 2H, J = 7.27 Hz, CH2), 6.24 (s, 1H, CH=C), 7.24-7.39 (m, 8H, 2 C6H4), 8.29 (s, 
1H, NH, D2O exchangeable). 
13C NMR (DMSO): 16.3 (ester CH3), 52.2 (ester CH2), 89.5, 90.1 
(CH=C),   120.3, 122.7, 124.8, 125.2, 126.4, 127.4, 127.9, 128.3, 128.6 (C6H5, C6H4), 164.5 
(CO), 172.4 (C=N); Anal. calcd for C18H15ClN2O2: C, 66.16; H, 4.63; N, 8.57%. Found: C, 
66.09; H, 4.83; N, 8.59%.  MS:  m/z: (%) 326 (M+, 60%). 
 
General procedure for the synthesis of the pyrazole derivatives 9a-c 
 
To a solution of either compound 7a (3.22 g, 0.01 mol) with either of hydrazine hydrate (0.50 g, 
0.01 mol) or phenylhydrazine (1.08 g, 0.01 mol) or compound 7c (3.26 g, 0.01 mol) with 
hydrazine hydrate (0.50 g, 0.01 mol) was added. The reaction mixture, in each case, was heated 
under reflux for 6 h then poured onto ice/water mixture containing few drops of hydrochloric 
acid and the formed solid product was collected by filtration.  
 
4-(1H-Benzo[d]imidazol-2-yl)-5-phenyl-1H-pyrazol-3-ol (9a). Light brown crystals from 
ethanol; yield: 2.32 g (84%); m.p. 106 oC. IR, : 3569-3329 (OH, 2NH), 3055 (CH aromatic), 
1644 (C=N), 1630 (C=C). 1H-NMR: : 7.27-7.42 (m, 9H, C6H5, C6H4), 8.27, 8.31 (2s, 2H, 
2NH, D2O exchangeable), 10.28 (s, 1H, OH, D2O exchangeable). 
13C NMR (DMSO):  142.6, 
143.8 (pyrazole C-4, C-5), 119.8, 120.5, 122.8, 123.6, 124.1, 124.5, 126.8, 127.1, 129.4, 130.6 
(C6H5, C6H4), 172.6, 176.2 (2C=N); Anal. calcd for C16H12N4O: C, 69.55; H, 4.38; N, 20.28%.  
Found: C, 69.73; H, 4.51; N, 20.37%. MS: m/z: (%) 276 (M+, 38%).  
 
4-(1H-Benzo[d]imidazol-2-yl)-5-(4-chlorophenyl)-1H-pyrazol-3-ol (9b). Light brown crystals 
from ethanol; yield: 2.45 g (79%); m.p. 208-211 oC. IR, : 3523-3321 (OH, 2NH), 3055 (CH 
aromatic), 1646 (C=N), 1630 (C=C). 1H-NMR: : 7.22-7.39 (m, 8H, 2C6H4), 8.29, 8.33 (2s, 2H, 
2NH, D2O exchangeable), 10.26 (s, 1H, OH, D2O exchangeable). 
13C NMR (DMSO): 143.9, 
142.4 (pyrazole C-4, C-5), 119.6, 120.8, 123.3, 123.9, 124.2, 124.8, 126.8, 128.9, 129.4, 130.8 
(C6H5, C6H4), 176.4, 172.5 (2C=N); Anal. calcd for C16H11ClN4O: C, 61.84; H, 3.57; N, 18.03%.  
Found: C, 61.95; H, 3.84; N, 17.89%. MS:  m/z: (%) 310 (M+, 30%).  
 
4-(1H-Benzo[d]imidazol-2-yl)-1,5-diphenyl-1H-pyrazol-3-ol (9c). Yellow crystals from 1,4-
dioxane; yield: 2.32 g (66%); m.p. 152-154 oC. IR, : 3520-3349 (OH, NH), 3053 (CH 
aromatic), 1642 (C=N), 1633 (C=C); 1H-NMR: : 7.26-7.37 (m, 14H, 2C6H5), 8.25 (s, 1H, NH, 
D2O exchangeable), 10.29 (s, 1H, OH, D2O exchangeable). 
13C NMR (DMSO): 144.2, 142.6 
(pyrazole C-4, C-5), 119.9, 120.3, 123.1, 123.6, 124.1, 124.3, 125.2, 125.3, 126.2, 126.8, 127.0, 
127.6, 128.2, 130.8  (C6H4, 2C6H5), 176.2, 172.7 (2C=N);  Anal. calcd for C22H16N4O: C, 74.98; 
H, 4.58; N, 15.90%.  Found: C, 75.22; H, 4.72; N, 15.73%.  MS: m/z: (%) 352 (M+, 21%).  
 
Ethyl 1-amino-2-cyano-3-phenylbenzo[4,5]imidazo[1,2-a]pyridine-4-carboxylate (11) 
 
To a solution of compound 6a (3.33 g, 0.01 mol) in ethanol (40 mL) containing triethylamine 
(0.50 mL), malononitrile (0.66 g, 0.01 mol) was added. The reaction mixture was heated under 
reflux for 6 h then poured onto ice/water mixture containing few drops of hydrochloric acid and 
the formed solid product was collected by filtration. Yellow crystals from 1,4-dioxane; yield: 
2.42 g (80%); mp: 82 oC. IR, : 3488-3343 (NH2), 3056 (CH aromatic), 2927, 2860 (CH3, CH2), 
2225 (CN), 1687 (CO), 1640 (C=N), 1636 (C=C). 1H-NMR: : 1.15 (t, 3H, J = 6.89 Hz, CH3), 
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4.23 (q, 2H, J = 6.89 Hz, CH2), 4.83 (s, 2H, NH2, D2O exchangeable), 7.28-7.42 (m, 9H, C6H5, 
C6H4). 
13C NMR (DMSO): 16.4 (ester CH3), 52.5 (ester CH2), 116.8 (CN), 119.3, 120.1, 123.5, 
124.3, 125.4, 125.9, 126.2, 128.8, 137.3, 140.8, 144.3, 143.2, (pyridine C-2, C-3, C-4, C-5, 
C6H5, C6H4), 164.8 (CO), 172.4 (C=N); Anal. calcd for C21H16N4O2: C, 70.77; H, 4.53; N, 
15.72%. Found: C, 70.93; H, 4.70; N, 15.63%. MS m/z (%) 356 (M+, 38%).  
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)-3-phenylbut-2-enoate (13) 
 
To the dry solid of compound 3 (2.04 g, 0.01 mol) ammonium acetate (0.50 g) and 
acetophenone (1.20 g, 0.01 mol) were added. The reaction mixture was heated in an oil bath at 
120 oC for 30 min then left to cool. The product was triturated with ethanol and the formed solid 
product was collected by filtration. Pale yellow crystals from 1,4-dioxane; yield: 1.69 g (69%); 
m.p. 240-243 oC. IR, : 3463-3379 (NH), 3057 (CH aromatic), 2955, 2860 (CH3, CH2), 1689 
(CO), 1638 (C=N), 1633 (C=C). 1H-NMR: : 1.14 (t, 3H, J = 6.07 Hz, CH3), 2.87 (s, 3H, CH3), 
4.22 (q, 2H, J = 6.07 Hz, CH2), 7.25-7.40 (m, 9H, C6H5, C6H4), 8.30 (s, 1H, NH, D2O 
exchangeable). 13C NMR (DMSO): 16.3 (ester CH3), 52.2 (ester CH2), 86.8, 90.4 (C=C), 120.6, 
121.2, 123.2, 123.8, 124.1, 125.3, 128.6, 129.4 (C6H5, C6H4), 164.5 (CO), 173.1 (C=N); Anal. 
calcd for C19H18N2O2: C, 74.49; H, 5.92; N, 9.14%.  Found: C, 74.53; H, 5.88; N, 9.08%. MS: 
m/z: (%) 306 (M+, 28%).  
 
General procedure for the synthesis of the ylidene derivatives 15a, b 
 
To the dry solid of compound 3 (2.04 g, 0.01 mol) ammonium acetate (0.50 g) either 
cyclophentanone (0.78 g, 0.01 mol) or cyclohexanone (0.92 g, 0.01 mol) were added. The 
reaction mixture was heated in an oil bath at 120 oC for 1 h then left to cool. The product was 
triturated with ethanol and the formed solid product was collected by filtration. 
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)-2-cyclopentylideneacetate (15a). Pale yellow crystals from 
ethanol; yield: 2.53 g (83%); m.p. 155 oC. IR, : 3459-3322 (NH), 3053 (CH aromatic), 2929, 
2863 (CH3, CH2), 1686 (CO), 1636 (C=N), 1630 (C=C). 
1H-NMR: : 1.13 (t, 3H, J = 6.93 Hz, 
CH3), 1.18-1.24 (m, 4H, 2CH2), 2.19-2.21 (m, 4H, 2CH2), 4.22 (q, 2H, J = 6.93 Hz, CH2), 7.27-
7.38 (m, 4H, C6H4), 8.32 (s, 1H, NH, D2O exchangeable). 
13C NMR (DMSO): 16.2 (ester CH3), 
1.89-2.13 (2m 4CH2), 52.6 (ester CH2), 86.4, 90.6 (C=C), 120.3, 121.2, 123.2, 125.6, 128.6 
(C6H4), 164.8 (CO), 173.2 (C=N); Anal. calcd for C16H18N2O2: C, 71.09; H, 6.71; N, 10.36%. 
Found: C, 70.93; H, 6.93; N, 10.47%.  MS: m/z: (%) 270 (M+, 36%).  
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)-2-cyclohexylideneacetate (15b). Gray crystals from ethanol; 
yield: 2.33 g (77%); m.p. 120 oC. IR, : 3463-3319 (NH), 3048 (CH aromatic), 2929, 2868 
(CH3, CH2), 1688 (CO), 1632 (C=N), 1628 (C=C). 
1H-NMR: : 1.15 (t, 3H, J = 7.16 Hz, CH3), 
1.13-1.18 (m, 4H, 2CH2), 2.08-2.16 (m, 6H, 3CH2), 4.22 (q, 2H, J = 7.16 Hz, CH2), 7.23-7.36 
(m, 4H, C6H4), 8.30 (s, 1H, NH, D2O exchangeable). Anal. calcd for C17H20N2O2: C, 71.81; H, 
7.09; N, 9.85%.  Found: C, 71.63; H, 6.87; N, 9.62%. MS: m/z: (%) 284 (M+, 19%).  
 
Ethyl 1,3-dimethylbenzo[4,5]imidazo[1,2-a]pyridine-4-carboxylate (17) 
 
To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (40 mL) containing piperidine (0.50 
mL), acetylacetone (1.00 g, 0.01 mol) was added. The reaction mixture was heated under reflux 
for 2 h then poured onto ice/water mixture containing few drops of hydrochloric acid and the 
formed solid product was collected by filtration. Brown crystals from ethanol; yield: 1.67 g 
(73%); m.p. 233 oC. IR, : 3056 (CH aromatic), 2925, 2863 (CH3, CH2), 1684 (CO), 1644 
(C=N), 1631 (C=C).1H-NMR: : 1.13 (t, 3H, J = 7.22 Hz, CH3), 2.89, 2.93 (2s, 6H, 2CH3), 4.22 
(q, 2H, J = 7.22 Hz, CH2), 6.14 (s, 1H, pyridine H-3), 7.25-7.39 (m, 4H, C6H4). 
13C NMR 
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(DMSO): 16.6 (ester CH3), 23.8, 24.6 (2CH3), 52.5 (ester CH2), 121.2, 123.4, 124.8, 126.5, 
128.6, 129.4, 139.3, 141.8, 142.2, 142.6 (pyridine, C6H4), 164.3 (CO), 173.3 (C=N); Anal. calcd 
for C16H16N2O2: C, 71.62; H, 6.01; N, 10.44%. Found: C, 71.80; H, 5.82; N, 10.63%. MS: m/z: 
(%) 268 (M+, 37%).  
 
Ethyl 1,3-diaminobenzo[4,5]imidazo[1,2-a]pyridine-4-carboxylate (18) 
 
To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (40 mL) containing piperidine (0.50 
mL), malononitrile (0.66 g, 0.01 mol) was added. The reaction mixture was heated under reflux 
for 4 h then poured onto ice/water mixture containing few drops of hydrochloric acid and the 
formed solid product was collected by filtration. Light brown crystals from ethanol; yield: 2.32 
g (80%); m.p. 235-238 oC. IR, : 3880-3268 (2NH2), 3058 (CH aromatic), 2965, 2872 (CH3, 
CH2), 1689 (CO), 1642 (C=N), 1630 (C=C). 
1H-NMR: : 1.12 (t, 3H, J = 7.42 Hz, CH3), 4.22 
(q, 2H, J = 7.42 Hz, CH2), 4.72, 5.04 (2s, 4H, 2NH2, D2O exchangeable), 6.13 (s, 1H, pyridine 
H-3), 7.26-7.37 (m, 4H, C6H4).
 13C NMR (DMSO): 16.6 (ester CH3), 52.3 (ester CH2), 121.6, 
126.4, 127.1, 127.2, 128.8, 129.2, 139.2, 141.4, 142.0, 142.9 (pyridine, C6H4), 164.5 (CO), 
173.6 (C=N); Anal. calcd for C14H14N4O2: C, 62.21; H, 5.22; N, 20.73%.  Found: C, 62.38; H, 




To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (40 mL) hydrazine hydrate (0.50 g, 
0.01 mol) was added. The reaction mixture was heated under reflux for 6 h then poured onto 
ice/water mixture containing few drops of hydrochloric acid and the formed solid product was 
collected by filtration. Brown crystals from ethanol; yield: 1.15 g (80%); m.p. > 300 oC. IR, :  
3488-3429 (NH2, NH), 3054 (CH aromatic), 2983 (CH2), 1684 (CO), 1640 (C=N), 1630 (C=C). 
1H-NMR: : 4.93 (s, 2H, CH2), 4.89 (s, 2H, NH2, D2O exchangeable), 7.29-7.39 (m, 4H, C6H4), 
8.28, 8.32 (2s, 2H, 2NH, D2O exchangeable). 
13C NMR (DMSO): 52.8 (CH2), 120.3, 123.8, 
124.6, 126.4, 127.3, 129.8 (C6H4), 163.8 (CO), 173.4 (C=N); Anal. calcd for C9H10N4O: C, 




To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (40 mL) containing triethylamine 
(0.50 mL) phenylisothiocyanate (1.30 g, 0.01 mol) was added. The reaction mixture was heated 
under reflux for 4 h then poured onto ice/water mixture containing few drops of hydrochloric 
acid and the formed solid product was collected by filtration. Yellow crystals from ethanol; 
yield: 2.67 g (87%); m.p. 202 oC. IR, : 3057 (CH aromatic), 2980 (CH2), 1689 (CO), 1643 
(C=N), 1632 (C=C).1H-NMR: : 5.90 (s, 2H, pyrimidine CH2), 7.26-7.38 (m, 9H, C6H4, C6H5). 
13C NMR (DMSO): 54.2 (CH2), 120.3, 123.7, 124.1, 124.6, 124.9, 125.8, 129.3, 126.7, 127.2, 
128.2 (C6H5, C6H4), 163.4 (CO), 173.6 (C=N), 180.3 (C=S); Anal. calcd for C16H11N3OS: C, 
65.51; H, 3.78; N, 14.32; S, 10.93%. Found: C, 65.33; H, 4.02; N, 14.59; S, 11.27%. MS: m/z: 
(%) 293 (M+, 22%).  
 
General procedure for the synthesis of the thiophene derivatives 23a,b 
 
To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (40 mL) containing triethylamine 
(0.50 mL) elemental sulfur or either of malononitrile (0.66 g, 0.01 mol) or ethyl cyanoacetate 
(1.13 g, 0.01 mol) were added. The reaction mixture was heated under reflux for 4 h then poured 
onto ice/water mixture containing few drops of hydrochloric acid and the formed solid product 
was collected by filtration. 
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2-Amino-5-(1H-benzo[d]imidazol-2-yl)-4-hydroxythiophene-3-carbonitrile (23a). Dark brown 
crystals from ethanol; yield: 2.61 g (87%); m.p. 252 oC. IR, :  3572-3341 (OH, NH2, NH), 3054 
(CH aromatic), 2220 (CN), 1646 (C=N), 1628 (C=C). 1H-NMR: : 5.21 (s, 2H, NH2, D2O 
exchangeable), 7.31-7.39 (m, 4H, C6H4), 8.22 (s, 1H, NH, D2O exchangeable), 10.15 (s, 1H, 
OH, D2O exchangeable). 
13C NMR (DMSO): 116.8 (CN), 122.1, 121.3, 123.2, 125.3, 127.2, 
128.7 (C6H4), 173.4 (C=N); Anal. calcd for C12H8N4OS: C, 56.24; H, 3.15; N, 21.86; S, 12.51%.  
Found: C, 56.08; H, 3.28; N, 21.79; S, 12.73%. MS: m/z: (%) 256 (M+, 42%).  
 
Ethyl 2-amino-5-(1H-benzo[d]imidazol-2-yl)-4-hydroxythiophene-3-carboxylate (23b). Black 
crystals from ethanol; yield: 2.89 g (87%); m.p. 249 oC. IR, :  3559-3321 (OH, NH2, NH), 3058 
(CH aromatic), 2977, 2857 (CH3, CH2), 1688 (CO), 1643 (C=N), 1629 (C=C). 
1H-NMR: :  
1.14 (t, 3H, J = 7.42 Hz, CH3), 4.22 (q, 2H, J = 7.42 Hz, CH2), 5.14 (s, 2H, NH2, D2O 
exchangeable), 7.27-7.37 (m, 4H, C6H4), 8.24 (s, 1H, NH, D2O exchangeable), 10.32 (s, 1H, 
OH, D2O exchangeable). Anal. calcd for C14H13N3O3S: C, 55.43; H, 4.32; N, 13.85; S, 10.57%.  
Found: C, 55.22; H, 4.62; N, 14.09; S, 10.64%. MS: m/z: (%) 303 (M+, 52%).   
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)-3-ethoxyacrylate (25) 
 
To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (40 mL) containing piperidine (0.50 
mL) ethyl orthoformate (1,48 g, 0.01 mol) was added. The reaction mixture was heated under 
reflux for 6 h then poured onto ice/water mixture containing few drops of hydrochloric acid and 
the formed solid product was collected by filtration. Yellow crystals from ethanol; yield: 2.22 g 
(68 %); m.p. >300 oC. IR, : 3489-3351 (NH), 3057 (CH aromatic), 2983, 2866 (CH3, CH2), 
1704 (CO), 1646 (C=N), 1624 (C=C).  1H-NMR: : 1.11, 1.13 (2t, 6H, J = 7.03, 6.67 Hz, 
2CH3), 3.83, 4.20 (2q, 4H, J = 7.03, 6.67 Hz, 2CH2), 6.08 (s, 1H, CH=C), 7.23-7.39 (m, 4H, 
C6H4), 8.21 (s, 1H, NH, D2O exchangeable). 
13C NMR (DMSO): 16.3, 16.5 (two OCH2CH3),   
52.3, 52.8 (two OCH2CH3), 86.4, 90.8 (CH=C), 121.5, 122.9, 125.1, 126.4, 127.2, 128.6 (C6H4), 
164.5 (CO), 173.8 (C=N); Anal. calcd for C14H16N2O3: C, 64.60; H, 6.20; N, 10.76%. Found: C, 
64.81; H, 5.93; N, 10.59%. MS: m/z: (%) 260 (M+, 42%).  
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)-3-(phenylamino)acrylate (26) 
 
To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (40 mL) containing piperidine (0.50 
mL) ethyl orthoformate (1.48 g, 0.01 mol) and aniline oil (0.93 g, 0.01 mol) was added. The 
reaction mixture was heated under reflux for 3 h then poured onto ice/water mixture containing 
few drops of hydrochloric acid and the formed solid product was collected by filtration. Pale 
yellow crystals from ethanol; yield: 2.35 g (79%); m.p. >300 oC. IR, :  3471-3329 (NH), 3055 
(CH aromatic), 2980, 2873 (CH3, CH2), 1699 (CO), 1643 (C=N), 1629 (C=C). 
1H-NMR: :  
1.15 (t, 3H, J = 7.13 Hz, CH3), 4.23 (q, 2H, J = 7.13 Hz, CH2), 6.03 (s, 1H, CH=C), 7.26-7.42 
(m, 9H, C6H5, C6H4), 8.23, 8.34 (2s, 2H, 2NH, D2O exchangeable). 
13C NMR (DMSO): 16.2 
(ester CH3), 52.5 (ester CH2), 88.4, 90.3 (C=C), 120.6, 121.6, 123.6, 123.8, 124.1, 125.3, 126.4, 
127.3, 128.8, 129.5 (C6H5, C6H4), 164.8 (CO), 173.3 (C=N), Anal. calcd for C18H17N3O2: C, 
70.34; H, 5.58; N, 13.67%. Found: C, 70.29; H, 5.73; N, 13.82%. MS: m/z: (%) 307 (M+, 22%).  
 
Ethyl 1-amino-2-cyano-3-ethoxybenzo[4,5]imidazo[1,2-a]pyridine-4-carboxylate (28) 
 
To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (40 mL) containing piperidine (0.50 
mL) ethyl orthoformate (1.48 g, 0.01 mol) and malononitrile (0.66 g, 0.01 mol) was added. The 
reaction mixture was heated under reflux for 3 h then poured onto ice/water mixture containing 
few drops of hydrochloric acid and the formed solid product was collected by filtration. Yellow 
crystals from ethanol; yield: 2.22 g (83%); m.p. >300 oC. IR, : 3488-3337 (NH2), 3056 (CH 
aromatic), 2988, 2893 (CH3, CH2), 2220 (CN), 1688 (CO), 1643 (C=N), 1629 (C=C). 
1H-NMR: 
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: 1.13 (t, 3H, J = 6.79 Hz, CH3), 4.21 (q, 2H, J = 6.79 Hz, CH2), 4.93 (s, 2H, NH2, D2O 
exchangeable), 6.14 (s, 1H, pyridine H-4), 7.28-7.39 (m, 4H, C6H4). 
13C NMR (DMSO): 16.3, 
16.8 (two OCH2CH3), 52.4, 52.9 (two OCH2CH3), 116.4 (CN), 121.5, 122.9, 125.1, 127.2, 
128.6, 138.4, 140.1, 142.6, 142.7 (pyridine, C6H4), 164.2 (CO), 173.6 (C=N); Anal. calcd for 
C17H16N4O2: C, 62.95; H, 4.97; N, 17.27%. Found: C, 64.32; H, 4.60; N, 19.83%. MS: m/z: (%) 




To a solution of compound 3 (2.04 g, 0.01 mol) in ethanol (30 mL) containing piperidine (0.50 
mL) salicylaldehyde (1.22 g, 0.01 mol) was added. The reaction mixture, in each case, was 
heated under reflux for 3 h then poured onto ice/water mixture containing few drops of 
hydrochloric acid and the formed solid product was collected by filtration. Yellow crystals from 
1,4-dioxane; yield: 1.41 g (89%); m.p. 273 oC. IR, : 3458-3323 (NH), 3054 (CH aromatic), 
1690 (CO), 1641 (C=N), 1633 (C=C). 1H-NMR: : 6.09 (s, 1H, coumarin H-4), 7.26-7.42 (m, 
8H, 2C6H4), 8.09 (s, 1H, NH, D2O exchangeable). 
13C NMR (DMSO): 121.6, 122.4, 124.1, 
125.3, 126.4, 126.8, 128.2, 129.4, 130.3, 131.5, (C6H5, C6H4), 164.6 (CO), 173.4 (C=N); Anal. 
calcd for C16H10N2O2: C, 73.27; H, 3.84; N, 10.68%. Found: C, 73.40; H, 3.94; N, 10.42%. MS: 
m/z: (%) 262 (M+, 16%). 
 
General procedure for the synthesis of the annulated derivatives 32a, b 
 
To a solution of compound 31 (2.62 g, 0.01 mol) in 1,4-dioxane containing triethylamine (0.50 
mL) either -chloroacetone (32a) (0.92 g, 0.01 mol) or ethyl -chloroacetate (32b) (1.22 g, 0.01 
mol) was added. The reaction mixture in each case was heated under reflux for 4 h then 
evaporated under vacuum. The remaining product, in each case, was triturated with ethanol and 
formed solid product was collected by filtration. 
 
7-Methyl-1H-benzo[4,5]imidazo[1,2-a]chromeno[3,4-c]pyridin-1-one (32a). Green crystals 
from 1,4-dioxane; yield: 0.95 g (67%); m.p. 195 oC. IR, :  3056 (CH aromatic), 1687 (CO), 
1640 (C=N), 1629 (C=C). 1H-NMR: : 2.93 (s, 3H, CH3), 5.93 (s, 1H, pyridine H-4), 7.29-7.38 
(m, 8H, 2C6H4). Anal. calcd for C19H12N2O2: C, 75.99; H, 4.03; N, 9.33%.  Found: C, 75.72; H, 
3.83; N, 9.59%. MS: m/z: (%) 300 (M+, 36%). 
 
7-Hydroxy-1H-benzo[4,5]imidazo[1,2-a]chromeno[3,4-c]pyridin-1-one (32b). Yellow crystals 
from acetic acid; yield: 1.40 g (82%); m.p. 217 oC. IR, :  3522-3341 (OH), 3057 (CH aromatic), 
1689 (CO), 1642 (C=N), 1631 (C=C). 1H-NMR: : 5.90 (s, 1H, pyridine H-4), 7.26-7.41 (m, 
8H, 2C6H4), 10.26 (s, 1H, OH, D2O exchangeable). Anal. calcd for C18H10N2O3: C, 71.52; H, 




To a solution of compound 31 (2.62 g, 0.01 mol) in 1,4-dioxane containing triethylamine (0.50 
mL) either chloroacetylchloride (1.12 g, 0.01 mol) was added. The reaction mixture was heated 
under reflux for 4 h then evaporated under vacuum. The remaining product was triturated with 
ethanol and formed solid product was collected by filtration. Yellow crystals from acetic acid; 
yield: 2.55 g (69%); m.p. 263 oC. IR, : 3563-3319 (OH), 3055 (CH aromatic), 1688 (CO), 1640 
(C=N), 1629 (C=C).1H-NMR (DMSO-d6) : 5.93 (s, 1H, pyridine H-4), 7.24-7.35 (m, 8H, 
2C6H4), 10.28 (s, 1H, OH, D2O exchangeable). 
13C NMR (DMSO): 119.9, 120.3, 123.1, 123.6, 
124.1, 124.3, 125.2, 125.3, 127.6, 128.3, 129.4, 130.8, 140.6, 142.8, 143.2 (pyran, pyridine, 
2C6H4), 163.8 (CO), 176.6 (C=N); Anal. calcd for C18H10N2O3: C, 71.52; H, 3.33; N, 9.27%.  
Found: C, 71.72; H, 3.36; N, 9.66%. MS: m/z: 302 (M+, 40%).  
Rafat M. Mohareb and Marwa S. Gaman 




A solution of compound 31 (2.62 g, 0.01 mol) in acetic acid (10 mL) and acetic anhydride (5 
mL) was heated under reflux for 3 h then evaporated under vacuum. The remaining product was 
triturated with diethyl ether and the formed solid product was collected by filtration. Yellow 
crystals from acetic acid; yield: 1.56 g (74%); m.p. 292 oC. IR, : 3055 (CH aromatic), 1690, 
1678 (2CO), 1638 (C=N), 1632 (C=C). 1H-NMR: : 2.80 (s, 3H, CH3), 6.23 (s, 1H, coumarin H-
4), 7.26-7.39 (m, 8H, 2C6H4). 
13C NMR (DMSO): 24.6 (CH3), 119.3, 121.8, 123.1, 124.3, 125.0, 
126.1, 127.6, 128.0, 129.4, 130.8, 140.3, 142.3, 143.8 (pyran, 2C6H4), 165.2, 164.4 (2CO), 
176.6 (C=N); Anal. calcd for C18H12N2O3: C, 71.05; H, 3.97; N, 9.21%. Found: C, 71.33; H, 




To a solution of compound 31 (2.62 g, 0.01 mol) in ethanol (40 mL) containing triethylamine 
(0.50 mL) phenyl isothiocyanate (1.30 g, 0.01 mol) was added. The reaction mixture was heated 
under reflux for 6 h then evaporated under vacuum. The remaining product was triturated with 
ethanol and formed solid product was collected by filtration. Pale yellow crystals from acetic 
acid; yield: 2.85 g (70%); m.p. 194 oC. IR, : 3488-3349 (NH), 3055 (CH aromatic), 1689 (CO), 
1638 (C=N), 1632 (C=C).1H-NMR: : 6.33 (s, 1H, coumarin H-4), 7.26-7.38 (m, 13H, C6H5, 
2C6H4), 8.31 (s, 1H, NH, D2O exchangeable). 
13C NMR (DMSO): 119.3, 121.8, 122.6, 123.2, 
123.8, 124.3, 125.3, 125.8, 126.4, 127.6, 128.5, 129.4, 130.8, 140.3, 142.6, 142.9, (pyran, C6H5, 
2C6H4), 164.4 (CO), 176.3 (C=N), 180.3 (C=S); Anal. calcd for C23H15N3O2S: C, 69.50; H, 
3.80; N, 10.57; S, 8.07%. Found: C, 69.79; H, 3.68; N, 10.41; S, 8.19%. MS: m/z: (%) 397 (M+, 
32%).   
CONCLUSION 
 
Ethyl 2-(1H-benzo[d]imidazol-2-yl)acetate (3) was used for several heterocyclic transformation 
reactions. The antitumor evaluations of the newly synthesized products toward the three cancer 
cell lines MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), and SF-268 
(CNS cancer) showed that compounds 5a, 9b, 9c, 17, 23b and 38 were of the highest potencies 
among the synthesized compounds. The work showed that benzimidazole derivatives were 
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